Figure 3.

Plasma concentration–time curves for SRT2104 co-administered as an oral dose (0.25 g) and an i.v. microdose (100 μg). (Bioavailability study). •, 0.25 g oral dose; ○, 100 μg i.v. dose – total radioactivity; ▾, 100 μg i.v. dose – SRT2104